Aptamer-Mediated Doxorubicin Delivery Reduces HCC Burden in 3D Organoids Model

0
274
Investigators developed a specific aptamer against EpCAM and tested its potential as a drug delivery agent for hepatocellular carcinoma.
[Journal of Controlled Release]
AbstractGraphical Abstract